We are delighted to share that Neuro-Bio’s manuscript titled “A novel bioactive peptide, T14, selectively activates mTORC1 signalling: therapeutic implications for neurodegeneration and other rapamycin-sensitive applications”, has been accepted for...
We are pleased to share that Baroness Professor Susan Greenfield, CEO of Neuro-Bio was interviewed by impactful Spanish newspaper “El Periodico”. You can read and watch the interview that echoes the important message and research regarding Alzheimer’s, below :...
Neuro-Bio is delighted to welcome Amelia Ghanea-Hercock as Student Scientist. Amelia is a second-year Neuroscience undergraduate at the University of Bristol. During this time, she has also been a Research Assistant and Founder’s Associate at a London-based...
Neuro-Bio is delighted to welcome Samuele Appiah as Finance Assistant. Samuele has gained experience throughout his academic year at Oxford Brookes university, giving him an opportunity to take a placement year at Groupe PSA as their commercial expense analyst,which...
Sibora Nastasi, a year ten student at the Bartholomew School in Eynsham, has spent a week in Neuro-Bio as part of her school “Work Experience “program. The aim of her placement, and due to her interest in Biology, was to understand how a Biotech company works. This is...
Neuro-Bio is delighted to welcome Kieran Bains as Office Manager. Kieran has worked across a range of backgrounds and specialisms in the education sector, gaining a multitude of experience in coordination, leadership, administration and public relations. She is...
Neuro-Bio is delighted to welcome Helen Collins as Senior Scientist. Helen received her DPhil in Neuroscience from the University of Oxford in 2023. She developed a mouse model of Antidepressant Discontinuation Syndrome, with which she investigated changes in...
Neuro-Bio is delighted to welcome Princess Kwangware as Executive Assistant to CEO. Princess worked as a web and e-commerce consultant and has gained project management experience across multiple industries among retail, education, and financial services....
On Friday 24th March, Neuro-Bio was mentioned in the Health Investor UK. The article talked about the current series C fundraise and the previous ones, quoting a message from CEO, Susan Greenfield : “It’s time we had a paradigm shift in AD. It’s time...
Neuro-Bio is delighted to share here the link to the podcast in which Baroness Susan Greenfield, Dr Richard Mohs and Dr Michal Zurawski talked about the work Neuro-Bio and Clota Varde are doing. Click here for watching the video....
